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Sharpless oxidationAbstract In this work, synthesis and characterization of a series of D-Mannitol derivatives with
sulﬁte 2a–d and sulfate 3a–d moieties have been investigated. The method entails a two-step
synthesis. The ﬁrst step involves the Sharpless-type reaction of DIOL 1a–d with SOCl2 in CH2Cl2
in the presence of Et3N to afford the intermediate sulﬁte derivatives 2a–d in good yield. The second
step includes the oxidation reaction of the resulting intermediate in the presence of NaIO4 in a mix-
ture of CCl4/CH3CN/H2O (3/3/2 ratio) in the presence of catalytic amount of RuCl3ÆH2O to afford
the desired sulfate moiety 3a–d in a moderate to high yield (66–96%). The structures of all newly
synthesized compounds have been elucidated by 1H, 13C NMR, GCMS, and IR spectrometry.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
The incidences of drug resistance of microorganisms to anti-
bacterial agents were constantly reported for the past few years
[6]. Subsequently, there is an urgent need for the development
of new drug molecules with newer targets, more potent,
selective non-traditional antimicrobial agents and with an
alternative mechanism of action. Organic molecules possessingsulfate moieties are increasingly gaining importance as modu-
lators of physiological or pathological function [12]. These
functions include inhibition of viral infection [10,15,20,26],
and clotting [2,3,6,7,13,14,18,21,23,24]. Yet, the number of
multiple sulfated synthetic, organic molecules available for
investigation remains small, primarily because of difﬁculties
in synthesis and isolation. As the structural diversity in organic
sulfate molecules increases, better modulators are expected.
For decades natural and synthetic polymers carrying sulfate
groups (dextran sulfate, carrageenan, heparin, polyvinyl sul-
fate, chondroitin sulfate, and others) have been known to have
strong complement-inhibiting properties [19,16,22,25,27].
Xing et al. had found that all kinds of sulfated chitosans
possessed antioxidant activities and free radical scavenging
activities [28,29]. Different bulkyarenesulfonylquinolones
based on norﬂoxacin and ciproﬂoxacin scaffolds were reported
with signiﬁcant antibacterial activity [1].
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describes the synthesis, and characterization of some new
sulﬁte and sulfate moieties.
2. Experimental
2.1. General
All the moisture and air sensitive reactions were carried out un-
der an inert atmosphere of argon ﬁlled glove box and standard
Schlenk-line techniques. All the chemicals were purchased from
Aldrich, Sigma–Aldrich, Fluka etc., and were used without fur-
ther puriﬁcation, unless otherwise stated. Toluene was distilled
using Na/benzophenone. CH2Cl2 was dried from CaH2. Silica
gel (SiO2; 100–200 mesh) was used for Flash column chroma-
tography. All melting points were measured on a Gallenkamp
melting point apparatus in open glass capillaries and are uncor-
rected. IR Spectra were measured as KBr pellets on a Nicolet
6700 FT-IR spectrophotometer. The NMR spectra were re-
corded on a Varian Mercury Jeol-400 NMR spectrometer.
1H-NMR (400 MHz), 13C-NMR (100 MHz) and 31P-NMR
were run in deuterated chloroform (CDCl3). Chemical shifts
(d) are referred in terms of ppm and J-coupling constants are
given in Hz. Mass spectra were recorded on a Jeol of JMS-
600 H. Elemental analysis was carried out on Elmer 2400 Ele-
mental Analyzer; CHN mode. Speciﬁc optical rotations were
measured on a highly sensitive automatic ‘A. KRU¨SS OPTRO-
NOCS’ polarimeter using sodium light (D line 589 nm).
2.1.1. General procedure for the synthesis of sulﬁte derivatives
2a–d (GP1)
In a two neck round bottom ﬂask, DIOL 1a–d (2.8 mmol) and
Et3N (1.57 mL) were dissolved in CH2Cl2 (10 mL). The reac-
tion mixture was cooled at 0 C, and SOCl2 (0.3 mL, 4.2 mmol)
in CH2Cl2 (1.0 mL) was added drop wise over 15 min, then the
reaction was continued for further 15 min, (TLC: EtOAc/Pe-
t.ether 1:2). The reaction mixture was extracted with CH2Cl2,
washed with brine, and dried over MgSO4, passed through
short pad of silica gel, washed with CH2Cl2, and solvent was
evaporated to afford the desired sulﬁtes 2a–d.
2.1.2. (4aR,7aR,11aS,11bS)-2,10-Diphenylhexahydrobis
([1,3]dioxino)[5,4-d:40,50-f][1,3,2]dioxathiepine 6-oxide 2a
2a was prepared according to general procedure (GP1), Yield
(930 mg, 2.3 mmol, 82%). m.p: 230 C; IR (KBr, cm–1): 1610,
1545, 1071;1H-NMR (400 MHz, CDCl3): d 7.49–7.35 (m, 10H,
2Ph), 5.53 (s, 2H, PhCH), 5.03 (m, 1H, CHOSO), 4.36 (m, 2H,
CHO), 4.26 (m, 1H, CHOSO), 4.06 (t, 1H, J= 8.8 Hz, OCH2),
3.94 (t, 1H, J= 8.8 Hz, OCH2), 3.85 (t, 2H, J= 10.2 Hz,
OCH2);
13C-NMR (100 MHz, CDCl3): d= 136.6, 129.3,
128.4, 126.3, 101.2, 101.0, 81.4, 79.5, 68.4, 64.8, 59.8; MS
(m/z): 405.40 (M+1)+, 47%; Anal. for C20H20O7S; calcd: C,
59.40; H, 4.98; Found: C, 59.42; H, 5.00.
2.1.3. (4aR,7aR,11aS,11bS)-2,10-di-p-tolylhexahydrobis
([1,3]dioxino)[5,4-d:40,50-f][1,3,2]dioxathiepine 6-oxide 2b
2b was prepared according to general procedure (GP1), Yield
(1.058 g, 2.44 mmol, 95% yield). M.p: 240 C; IR (KBr, cm–1):
3200, 1600, 1540, 1072; 1H-NMR (400 MHz, CDCl3): d 7.36–
7.35 (dd, 2H, J= 5.1 Hz, J= 7.3 Hz, Ph), 5.48 (s, 2H,
PhCH), 5.00 (m, 1H, CHOSO), 4.38 (m, 2H, CHO), 4.25 (m,1H, CHOSO), 4.02 (t, 1H, J= 8.0 Hz OCH2), 3.91 (t, 1H,
J= 8.8 Hz, OCH2), 3.82 (t, 2H, J= 10.2 Hz, OCH2), 2.33
(s, 3H, CH3);
13C-NMR (100 MHz, CDCl3): d 139.2, 133.9,
129.0, 126.2, 101.2, 81.4, 79.5, 68.5, 59.9, 21.4; MS (m/z):
433.50 (M+1)+, 78%; Anal. for C22H24O7S; calcd: C, 61.10;
H, 5.59; Found: C, 61.12; H, 5.60.
2.1.4. (4aR,7aR,11aS,11bS)-2,10-bis(4-methoxyphenyl)
hexahydrobis([1,3]dioxino)[5,4-d:40,50-f][1,3,2]dioxathiepine
6-oxide 2c
2c was prepared according to general procedure (GP1), Yield
(580 mg, 1.03 mmol, 71% yield) m.p.: 122 C; IR (KBr, cm–
1): 3100, 1578, 1543,1072; 1H-NMR (400 MHz, CDCl3): d
7.88 (d, 2H, J= 6.6 Hz, Ph), 7.44 (d, 2H, J= 8.8 Hz, Ph),
7.05 (d, 2H, J= 8.8 Hz, Ph), 6.92 (d, 2H, J= 6.6 Hz, Ph),
5.51 (s, 2H, PhCH), 5.02 (m, 1H, CHOSO), 4.37 (m, 2H,
CHO), 4.34 (m, 1H, CHOSO), 4.05 (t, 1H, J= 8.0 Hz,
OCH2), 3.91 (t, 1H, J= 8.0 Hz, OCH2), 3. 85 (m, 2H,
OCH2), 3.82 (s, 3H, OCH3);
13C-NMR (100 MHz, CDCl3): d
132.1, 130.0, 127.7, 114.4, 113.7, 101.2, 81.4, 68.5, 64.9, 55.4;
MS (m/z): 465.49 (M+1)+, 94%; Anal. for C22H24O9S; calcd:
C, 56.89; H, 5.21; Found: C, 56.88; H, 5.20.
2.1.5. (4aR,7aR,11aS,11bS)-2,10-bis(2,4-dichlorophenyl)
hexahydrobis([1,3]dioxino)[5,4-d:40,50-f][1,3,2]dioxathiepine
6-oxide 2d
2d was prepared according to general procedure (GP1), Yield
(880 mg, 1.62 mmol, 81% yield) m.p.: 95 C; IR (KBr, cm–1):
1578, 1543, 1072; 1H-NMR (400 MHz, CDCl3): d 7.55 (s,
2H, Ph), 7.38 (m, 4H, Ph), 6.02 (s, 2H, PhCH), 5.00 (m, 1H,
CHOSO), 4.66 (m, 2H, CHO), 4.34 (m, 1H, CHOSO), 4.19
(t, 1H, J= 8.0 Hz, OCH2), 4.08 (t, 1H, J= 8.0 Hz OCH2),
3. 95 (m, 2H, OCH2);
13C-NMR (100 MHz, CDCl3): d 136.0,
133.0, 129.9, 128.7, 127.2, 101.3, 84.2, 83.0, 67.9, 65.6; MS
(m/z): 543.21 (M+1)+, 85%; Anal. for C20H16Cl4O7S; calcd:
C, 44.30; H, 2.97; Found: C, 44.33; H, 3.00
2.1.6. General procedure for the synthesis of sulfate derivatives
3a–d (GP2)
A two necked round bottom ﬂask was charged with sulﬁte
(1.81 mmol) in CCl4 (15 mL), and CH3CN (15 mL). After
cooling at 0 C, H2O (10 mL) was added and then a mixture
of RuCl3ÆH2O (0.011 mmol) and NaIO4 (4.57 mmol) was
added in one portion. The mixture was stirred vigorously at
0 C for 90 min (TLC: EtOAc/Pet.Ether 3:1), extracted with
Et2O, washed with brine, MgSO4, and the solvent was re-
moved to afford 3a–d.
2.1.7. (4aR,7aR,11aS,11bS)-2,10-diphenylhexahydrobis
([1,3]dioxino)[5,4-d:40,50f][1,3,2]dioxathiepine 6,6-dioxide 3a
3a was prepared according to general procedure (GP2), Yield
(white solid, 550 mg, 1.30 mmol, 66% yield); m.p: 124 C; IR
(KBr, cm–1): 1560, 1532, 1070; 1H-NMR (400 MHz, CDCl3):
d 7.49–7.34 (m, 10H, Ph), 5.54 (s, 21H, PhCH), 4.73 (m, 2H,
CHOSO), 4.53 (q, 2H, J= 5.5 Hz, CHO), 4.14 (dd, 2H,
J= 7.3 Hz, J= 1.8 Hz, OCH2) 3.87 (t, 2H, J= 10.6 Hz,
OCH2);
13C-NMR (100 MHz, CDCl3): d 136.0, 129.6, 128.5,
126.2, 101.4, 79.4, 70.8, 67.2; MS (m/z): 421.44 (M+1)+,
86%; Anal. for C20H20O8S; calcd: C, 57.13; H, 4.79; Found:
C, 57.12; H, 4.80.
Figure 1 1HNMR spectrum of 2a.
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dioxino)[5,4-d:40,50-f][1,3,2]dioxathiepine 6,6-dioxide 3b
3b was prepared according to general procedure (GP2), Yield
(white solid, 700 mg, 1.56 mmol, 86% yield); m.p: 160 C; IR
(KBr, cm–1): 1563, 1520, 1060; 1H-NMR (400 MHz, CDCl3):
d 7.35 (d, 4H, J= 8.0 Hz, Ph), 7.18 (d, 4H, J= 8.0 Hz, Ph),
5.49 (s, 2H, PhCH), 4.68 (m, 2H, CHOSO), 4.50 (q, 2H,
J= 5.5 Hz, CHO), 4.10 (dd, 2H, J= 7.3 Hz, J= 1.8 Hz,
OCH2) 3.84 (t, 2H, J= 10.6 Hz, OCH2), 2.34 (s, 3H, CH3);
13C-NMR (100 MHz, CDCl3): d 139.5, 133.3, 129.1, 129.0,
126.2, 101.5, 79.5, 70.9, 67.2, 64.9; MS (m/z): 449.47
(M+1)+, 86%; Anal. for C22H24O8S; calcd: C, 58.92; H,
5.39; Found: C, 58.93; H, 5.38
2.1.9. (4aR,7aR,11aS,11bS)-2,10-bis(4-methoxyphenyl)
hexahydrobis([1,3]dioxino)[5,4-d:40,50-f][1,3,2]dioxathiepine
6,6-dioxide 3c
3c was prepared according to general procedure (GP2), Yield
(white solid, 600 mg, 1.25 mmol, 96% yield); m.p.: 105 C;
IR (KBr, cm–1): 1560, 1523,1055; 1H-NMR (400 MHz,
CDCl3): d 7.84 (d, 2H, J= 8.8 Hz, Ph), 7.39 (dd2H,
J= 8.0 Hz, J= 4.4 Hz, Ph), 7.00 (d, 2H, J= 8.8 Hz, Ph),
6.88 (dd, 2H, J= 8.8 Hz, J= 2.2 Hz, Ph), 5.46 (s, 2H,
PhCH), 5.00 (m, 2H, CHOSO), 4.40 (q, 2H, J= 5.5 Hz,
CHO), 4.00 (dd, 2H, J= 7.3 Hz, J= 1.8 Hz, OCH2) 3.84 (t,
2H, J= 10.6 Hz, OCH2), 3.88 (s, 3H, OCH3);
13C-NMR
(100 MHz, CDCl3): d 132.1, 130.0, 127.7, 114.4, 113.6, 101.2,
81.4, 64.9, 59.9; MS (m/z): 481.48 (M+1)+, 82%; Anal. for
C22H24O10S; calcd: C, 54.99; H, 5.03; Found: C, 55.00; H, 5.02.
2.1.10. (4aR,7aR,11aS,11bS)-2,10-bis(2,4-dichlorophenyl) hexa-
hydrobis([1,3]dioxino)[5,4-d:40,50-f][1,3,2]dioxathiepine 6,6-
dioxide 3d
3d was prepared according to general procedure (GP2), Yield
(white solid, 580 mg, 1.03 mmol, 71% yield); m.p.: 122 C; IR
(KBr, cm–1): 1566, 1501,1045; 1H-NMR (400 MHz, CDCl3): d
7.30 (s, 2H, Ph), 7.20 (m, 4H, Ph), 6.10 (s, 2H, PhCH), 4.85 (m,
2H, CHOSO), 4.63 (m, 2H, CHO), 4.41 (dd, 2H, J= 9.5 Hz,
J= 2.2 Hz, OCH2), 4.13 (d, 2H, J= 8.8 Hz, OCH2);
13C-
NMR (100 MHz, CDCl3): d 136.3, 134.1, 132.6, 129.9, 128.7,
127.3, 101.5, 81.8, 80.8, 74.4, 66.9; MS (m/z): 559.20
(M+1)+, 79%; Anal. for C20H16Cl4O8S; calcd: C, 43.03; H,
2.89; Found: C, 43.09; H, 2.92.Scheme 1 Synthesis of sulﬁte derivatives 2a–d and sulfate derivatives 3a–d.
Figure 2 The chemical structure of 2a.
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In continuation of our research program [9,11,17], according
to the procedure described by K. Sharpless some modiﬁcation
treatment of DIOL 1a–d with SOCl2 in CH2Cl2 in the presence
of Et3N as base at 0 C afforded sulﬁte intermediates 2a–d in
good yield as depicted in Scheme 1.
It is assumed that the product 2a–d was formed via double
nucleophilic attack of the hydroxyl group of DIOL 1a–d on the
S‚O group followed by elimination of Cl as the leaving
group. The disappearance of the stretching band of OH group
at 3400 cm1 was conﬁrmed by IR. The structures of all new
compounds 2a–d are in good agreement with their analytical
and spectroscopic data.
Subsequently, 2a–d was subjected to oxidation using NaIO4
in a mixture of CCl4/CH3CN/H2O:3/3/2 ratio in the presence
of catalytic amount of RuCl3ÆH2O to afford 3a–d in a moder-
ate to high yield (66–96%). Their formations were conﬁrmed
and elucidated by 1H, 13C NMR, MS and IR spectra in addi-
tion to elemental analysis.Sulﬁte derivatives 2a–d Sulfate derivatives 3a–dO
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Figure 4 1HNMR spectrum of 3a.
Figure 6 3D-using ChemDraw after minimization energy and
run stereochemistry detection 3a.
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plet signal in the aromatic region assignable to phenyl protons.
A singlet signal at d 5.53 ppm is due to benzylic protons. The
region of d 5.01–3.84 is assigned to the 8 protons from 2CH2,
4CH as depicted in Fig. 1.Figure 5 3D-using ChemDraw after minimization energy and
run stereochemistry detection for 2a.In order to assign the 1H-NMR, a sample was submitted to
COSY-NMR Fig. 3.
The COSY-NMR (CDCl3) spectrum of 2a displayed that
proton of H1 at d 5.01 ppm as multiplet that because coupled
with H2, H3 and H5. A multiplet signal at d 4.37 ppm assigned
for H5 and H50 where coupled with H1, H2 and H3. At d
4.26 ppm multiplet signal assigned for the H10 at d 5.01 ppm
as multiplet that because coupled with H20, H30 and H50. A
triplet signal at d 4.06 ppm assigned for H2 and coupled with
H1, H3. A triplet signal at d 3.94 ppm assigned for H20 and
coupled with H10, H30. Finally, triplet signal at d 3.85 ppm as-
signed for two proton H3 and H30 where coupled with H1, H2
and H10, H20, respectively (Fig. 2).
The 1H-NMR (CDCl3) spectrum of 3a displayed a multiplet
signal in the aromatic region assignable to phenyl protons. A
singlet signal at d 5.54 ppm is due to benzylic protons. The
region of d 4.50–3.87 is assigned to the 8 protons from
2CH2, 4CHas depicted in Fig. 4. The spectra show that the com-
pound became more rigid and seems to be symmetrical (Figs. 5
and 6).
4. Conclusion
From the obtained results, we can summarize that we have
successfully prepared a series of sulﬁte derivatives 2a–d and
sulfate derivatives 3a–d in excellent yield up 96% in two
steps starting from DIOL 1a–d. The full scope, asymmetric
transformations and its application in the synthesis of bio-
logically active molecules are currently underway in our
laboratory.
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